All lobbying filings
DLA PIPER LLP (US)
DLA PIPER LLP (US) filed a Q2 report for CURRAX PHARMACEUTICALS LLC on July 21, 2025, reporting $50,000 in lobbying income.
Lobbying for CURRAX PHARMACEUTICALS LLC · Specialty pharmaceutical business
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Tennessee
Government bodies contacted
2
Lobbying activity
1
Legislative and regulatory policies and proposals related to obesity treatment. Drug compounding safety.